[The Communauté française' eradication plan for measles, mumps and rubella].
The combined vaccine against measles, mumps and rubella provides an efficient tool for the elimination of these three diseases in a community. In the French Community of Belgium the MMR vaccine is commercially available since 1984 and was officially included in the immunization schedule in 1985. The present coverage rate is estimated at 60% of the children under 24 month. To improve the situation, the "Conseil Consultatif Communautaire de Prévention pour la Santé" of the French Community of Belgium has proposed a programme of MMR immunization promotion based on a coordinated mobilization of the various structures involved i.e. MCH organization, school medicine, general practitioners, pediatricians, Faculties of medicine and Health Administration. The programme has been adopted by the political authority and has started on February 1st 1989.
Berghmans
L
L
Swennen
B
B
Dachy
A
A
Reginster
R
R
Thieffry
P
P
Drumaux
P
P
D001530:Belgium; D002648:Child; D002675:Child, Preschool; D004338:Drug Combinations / Q000627:therapeutic use; D006801:Humans; D007114:Immunization / Q000706:statistics & numerical data; D007223:Infant; D008458:Measles Vaccine / Q000627:therapeutic use*; D022542:Measles-Mumps-Rubella Vaccine; D009108:Mumps Vaccine / Q000627:therapeutic use*; D012411:Rubella Vaccine / Q000627:therapeutic use*
D004338:Drug Combinations; D008458:Measles Vaccine; D022542:Measles-Mumps-Rubella Vaccine; D009108:Mumps Vaccine; D012411:Rubella Vaccine
Le plan d'élimination de la Rougeole, de la Rubéole et des Oreillons de la Communauté francçaise.